Ricardo Coentre, PhD

Department of Psychiatry, Unidade Local de Saúde de Santa Maria, Lisbon, Portugal; University Clinic of Psychiatry and Medical Psychology, Faculty of Medicine, University of Lisbon, Lisbon, Portugal

  • 3Articles
  • 18.4KReads1
  • 2023–2026Active
  • 8Collaborators
  • 7Citations2

About

Ricardo Coentre, PhD, is affiliated with the Department of Psychiatry at Unidade Local de Saúde de Santa Maria and the University Clinic of Psychiatry and Medical Psychology at the University of Lisbon, Portugal. His publications from 2023 to 2026 focus on clinical topics including anxiety, with specific studies addressing benign ethnic neutropenia related to clozapine, quetiapine-induced neuroleptic malignant syndrome, and secondary social anxiety disorder in Huntington’s disease. He has collaborated frequently with co-authors such as Rodrigo Saraiva, Beatriz Côrte-Real, Catarina Cordeiro, Linda Azevedo Kauppila, and Manuela Abreu.

Publications

PCC
Benign Ethnic Neutropenia and Clozapine
Case Report

Benign Ethnic Neutropenia and Clozapine

January 22, 2026

This case highlights the importance of recognizing benign ethnic neutropenia to prevent unnecessary clozapine discontinuation.
, , , et al
PCC
Quetiapine-Induced Neuroleptic Malignant Syndrome
Case Report

Quetiapine-Induced Neuroleptic Malignant Syndrome

March 23, 2023

Clinicians should be aware of the possibility of neuroleptic syndrome developing, even with a widely used second-generation antipsychotic like quetiapine.
, , , et al
PCC
Social Anxiety Disorder in Huntington´s Disease
Case Report

Social Anxiety Disorder in Huntington´s Disease

March 21, 2023

A patient with no previous psychiatric disorder developed social anxiety after subtle motor manifestations of Huntington´s disease.
, , , et al

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Ketamine and Psychedelics

Listen to the Podcast
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe